Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Kinder Morgan reports Q3 results on October 14 with the stock up nearly 5% on the week, options traders leaning constructive, and a structural index question gathering in the background.
The positioning read heading into the print is notably relaxed. Short interest at 2.1% of the free float is low and has eased slightly over the past week, down around 0.8%. Borrow costs are minimal at 0.40%. Availability is essentially unlimited, with over 9,900% availability against outstanding short positions, meaning the lending market places no pressure whatsoever on bears or bulls from the financing side. Options positioning reinforces the calm: the put/call ratio of 0.50 sits just below its 20-day average of 0.52, a fraction below the neutral zone, with a z-score of -0.41. Neither the short book nor the options market is pricing meaningful downside risk ahead of Wednesday's print.
The analyst debate is a study in modest divergence rather than outright conviction. The consensus skews toward neutral, with the analyst recommendation differential scoring in the 92nd percentile, meaning KMI sits materially above average on that factor relative to peers. Most shops have migrated toward hold-equivalent ratings, with targets clustered in the $33 to $38 range against a current price of $32.49. The most recent moves tell a nuanced story: RBC lifted its target to $36 in late September while holding at Sector Perform, while Jefferies trimmed to $33 the week before, also holding at Hold. The bull case centres on fee-based cash flow stability, a growing project backlog including the Trident Intrastate Pipeline, and the emerging data centre gas demand angle. Bears point to commodity price sensitivity feeding through to contract renewal risk, project execution uncertainty, and the structural headwind from renewables eroding long-run volumes. The PE multiple, at just under 21x and up roughly 1 point over the past month as the stock has recovered, gives the earnings quality argument some extra relevance: a company priced for steady delivery has limited room to disappoint on throughput or guidance.
One angle that sits entirely outside the earnings narrative is worth flagging. ORTEX forecasts a 55% probability that KMI is deleted from the CRSP US Mega index at the December 2026 Quarterly Review, with a corresponding forecast of increased weighting in CRSP US Mid. The rank date is December 4, with any trade settling by December 23. The decisive price is $33.65: KMI currently trades 3.6% below that threshold. A strong earnings print that pushes the shares above that level would shift the rebalance calculus materially, while a weak reaction could cement the deletion case. These are ORTEX forecasts, not confirmed index actions.
The Q3 print will test whether the fee-based pipeline model continues to generate the predictable growth that keeps Kinder Morgan's de-rated yield story attractive, and whether management's project commentary is strong enough to justify the recent five-week rally against a backdrop of analyst ambivalence.
See the live data behind this article on ORTEX.
Open KMI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
